drugset / Trial / NCT04813445
Analysing the Effects of Xingnaojing for Mild-to-severe Acute Ischemic Stroke
Unknown
72 enrolled
Dongzhimen Hospital, Beijing
Affiliated Hospital of Chengde Medical University · collabAffiliated Hospital of Nantong University · collabNanjing Brian Hospital · collab
RandomizedParallel-groupSingle-blindOther
Summary
The main purpose of this trial is to analyse the Effects of Xingnaojing for Mild-to-severe Acute Ischemic Stroke by Metabonomics, proteomics and clinical parameters.
Timeline
- Start
- 2021-05-28
- Primary completion
- 2022-06-28
- Completion
- 2022-09-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Xingnaojing | Unknown | 20 ml | Intravenous |